Skip to main content

In Brief This Week: Sigma-Aldrich; Cyntellect; MIT

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich has launched a new life sciences brand platform in an effort to "elevate the company's current focus on biology and provide a single destination where researchers can access" biological knowledge, products, and technologies, the firm said in a statement this week. The new "Where Bio Begins" brand is meant to bring attention to the firm's biology focus.

Cyntellect will provide researchers at Harvard University and the Howard Hughes Medical Institute with its Leap Cell Processing Workstation. The researchers will work with Cyntellect's Stem Cell Manager on the Leap Workstation for projects aimed at selectively processing stem cells to "define the factors and mechanisms that regulate the migration, expansion, and regenerative potential of adult blood-forming and muscle-forming stem cells."

The David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology has received funding from the National cancer Institute to become a Center for Cancer Systems Biology. The MIT institute is one of 11 to be named centers. It did not disclose the amount of funding it received from NCI.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.